Related Experiment Video
Updated: Dec 13, 2025

11:58
A Protocol for Roux-en-Y Gastric Bypass in Rats using Linear Staplers
Published on: August 21, 2021
5.8K
Enhanced recovery after bariatric surgery (ERABS) protocol implementation in a laparoscopic center
Sergio Navarro-Martínez1, Juan Carlos Sebastián-Tomás1, José Ángel Diez Ares1
1Department of Digestive Surgery, Doctor Peset University Hospital, Valencia, Spain.
Summary
Enhanced recovery after bariatric surgery (ERABS) protocols significantly reduce hospital stays. This study found ERABS allows early discharge without increasing complications, readmissions, or mortality in bariatric patients.
Area of Science:
- Bariatric Surgery
- Surgical Protocols
- Patient Recovery
Background:
- Enhanced recovery after bariatric surgery (ERABS) protocols integrate preoperative, intraoperative, and postoperative strategies.
- ERABS aims to optimize surgical patient management and outcomes.
- Evaluating ERABS impact on length of stay and complications is crucial.
Purpose of the Study:
- To assess the effect of the ERABS protocol on length of hospital stay (LOS).
- To determine the impact of ERABS on postoperative complication rates.
- To evaluate ERABS influence on patient readmissions and mortality.
Main Methods:
- Retrospective analysis of 200 patients undergoing Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) from 2015-2018.
- Comparison between a pre-ERABS group (2015-2017) and an ERABS group (2018).
- Primary outcome: LOS; Secondary outcomes: readmission rates and 30-day postoperative complications.
Main Results:
- The ERABS group (80 patients) had a median LOS of 2 days, significantly shorter than the pre-ERABS group (120 patients) with 4 days (p < .0001).
- No significant differences observed in postoperative complication rates between the groups.
- Readmission rates and mortality showed no significant variations.
Conclusions:
- ERABS protocol implementation is associated with improved postoperative recovery.
- Early patient discharge is feasible with ERABS without compromising safety.
- ERABS does not increase postoperative complications, readmissions, or mortality.

